These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25794920)

  • 1. Fluorodeoxyglucose positron emission tomography/computed tomography for diagnosis of upper urinary tract urothelial carcinoma.
    Asai S; Fukumoto T; Tanji N; Miura N; Miyagawa M; Nishimura K; Yanagihara Y; Shirato A; Miyauchi Y; Kikugawa T; Yokoyama M
    Int J Clin Oncol; 2015 Oct; 20(5):1042-7. PubMed ID: 25794920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.
    Gomella LG; Mann MJ; Cleary RC; Hubosky SG; Bagley DH; Thumar AB; McCue PA; Lallas CD; Trabulsi EJ
    Can J Urol; 2017 Feb; 24(1):8620-8626. PubMed ID: 28263126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study.
    Zattoni F; Incerti E; Colicchia M; Castellucci P; Panareo S; Picchio M; Fallanca F; Briganti A; Moschini M; Gallina A; Karnes JR; Lowe V; Fanti S; Schiavina R; Rambaldi I; Ficarra V; Evangelista L
    Abdom Radiol (NY); 2018 Sep; 43(9):2391-2399. PubMed ID: 29302738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of upper urinary tract transitional cell carcinoma: the role of ureteroscopy, retrograde pyelography, cytology and urinalysis.
    Chen GL; El-Gabry EA; Bagley DH
    J Urol; 2000 Dec; 164(6):1901-4. PubMed ID: 11061876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating upper urinary tract urothelial carcinomas: a single-centre 10-year experience.
    Dev HS; Poo S; Armitage J; Wiseman O; Shah N; Al-Hayek S
    World J Urol; 2017 Jan; 35(1):131-138. PubMed ID: 27129575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of upper-tract cytology, retrograde pyelography, ureteroscopic appearance, and ureteroscopic biopsy with histologic examination of upper-tract transitional cell carcinoma.
    Williams SK; Denton KJ; Minervini A; Oxley J; Khastigir J; Timoney AG; Keeley FX
    J Endourol; 2008 Jan; 22(1):71-6. PubMed ID: 18315477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
    Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma.
    Messer JC; Terrell JD; Herman MP; Ng CK; Scherr DS; Scoll B; Boorjian SA; Uzzo RG; Wille M; Eggener SE; Lucas SM; Lotan Y; Shariat SF; Raman JD
    Urol Oncol; 2013 Aug; 31(6):904-8. PubMed ID: 21906967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinoma.
    Simon CT; Skala SL; Weizer AZ; Ambani SN; Chinnaiyan AM; Palapattu G; Hafez K; Magers MJ; Kaffenberger SD; Spratt DE; Montgomery JS; Morgan TM; Udager AM; Lew M; Mehra R
    Hum Pathol; 2019 Apr; 86():76-84. PubMed ID: 30537495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples.
    Pierconti F; Martini M; Fiorentino V; Cenci T; Racioppi M; Foschi N; Di Gianfrancesco L; Sacco E; Rossi E; Larocca LM; Bassi PF
    Hum Pathol; 2021 Dec; 118():42-48. PubMed ID: 34582934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does urinary cytology have a role in haematuria investigations?
    Tan WS; Sarpong R; Khetrapal P; Rodney S; Mostafid H; Cresswell J; Watson D; Rane A; Hicks J; Hellawell G; Davies M; Srirangam SJ; Dawson L; Payne D; Williams N; Brew-Graves C; Feber A; Kelly JD;
    BJU Int; 2019 Jan; 123(1):74-81. PubMed ID: 30003675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New classification of hydronephrosis on 18F-FDG-PET/CT predicts post-operative renal function and muscle-invasive disease in patients with upper urinary tract urothelial carcinoma.
    Asai S; Fukumoto T; Watanabe R; Koyama K; Sawada Y; Noda T; Miura N; Yanagihara Y; Miyauchi Y; Miyagawa M; Kikugawa T; Saika T
    Jpn J Clin Oncol; 2018 Nov; 48(11):1022-1027. PubMed ID: 30252103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
    Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
    BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial clinical experience with use of ureteral access sheaths in the diagnosis and treatment of upper tract urothelial carcinoma.
    Gorin MA; Santos Cortes JA; Kyle CC; Carey RI; Bird VG
    Urology; 2011 Sep; 78(3):523-7. PubMed ID: 21529901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence in situ hybridization for detecting upper urinary tract tumors--a preliminary report.
    Akkad T; Brunner A; Pallwein L; Gozzi C; Bartsch G; Mikuz G; Steiner H; Verdorfer I
    Urology; 2007 Oct; 70(4):753-7. PubMed ID: 17991550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary study of detecting urothelial malignancy with FDG PET in Taiwanese ESRD patients.
    Sun SS; Chang CH; Ding HJ; Kao CH; Wu HC; Hsieh TC
    Anticancer Res; 2009 Aug; 29(8):3459-63. PubMed ID: 19661374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
    Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of urine cytology and fluorescence in situ hybridization in upper urothelial tract samples.
    Reynolds JP; Voss JS; Kipp BR; Karnes RJ; Nassar A; Clayton AC; Henry MR; Sebo TJ; Zhang J; Halling KC
    Cancer Cytopathol; 2014 Jun; 122(6):459-67. PubMed ID: 24604675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma.
    Messer J; Shariat SF; Brien JC; Herman MP; Ng CK; Scherr DS; Scoll B; Uzzo RG; Wille M; Eggener SE; Steinberg G; Terrell JD; Lucas SM; Lotan Y; Boorjian SA; Raman JD
    BJU Int; 2011 Sep; 108(5):701-5. PubMed ID: 21320275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.